Anemia, Cancer
Conditions
Keywords
Cancer Anemia Survey, Chulalongkorn hospital
Brief summary
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
Detailed description
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered
Interventions
Tracking anemia management in Adult Cancer Patients
Sponsors
Janssen-Cilag Ltd.,Thailand
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with cancer
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients that have anemia during cancer therapy | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia | 6 months |
Countries
Thailand
Outcome results
None listed